Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Binmin Formula granules vs TCM decoction for persistent allergic rhinitis
ChiCTR2200061239Phase 3Not yet recruiting
- Sponsor
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of Bimin formula in allergic rhinitis (AR) (2 arms), sponsored by Guangdong Provincial Hospital of Traditional Chinese Medicine. Primary endpoint: Total nasal symptom score. Planned start Jun 2022; status: not yet recruiting.
02
Drugs
Bimin formula
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on ChiCTR2200061239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200061239.